OTC •
Healthcare •
Biotechnology •
Quote as of 09/08/2026 14:04
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.3401 mln
Float745 mln
Earnings Date11/19/2026
EPS
0.01
Marginal
P / E
0.04
Anomalous
Piotroski F-Score
3
/ 9
Below average
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
-0.28
Negative equity
Dividend Yield
0.00%
No dividend
Business Description
Aibotics Inc. is a Miami-based company focused on developing psychedelic-based treatments for people dealing with depression and anxiety, particularly those receiving end-of-life care. Previously operating under the name Mycotopia Therapies Inc., the company adopted its current name in early 2025.
